Delivery Order SPE2DB25D3110-SPE2DB25FTEKA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,600.81 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award for pharmaceutical supplies to be delivered to the Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,107.71 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on August 18, 2025, with a completion date of August 19, 2025. This firm fixed price delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs, specifically supporting military and veteran healthcare systems. The award was made through open competition with no set-aside designation,...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides Imitrex 6 mg/0.5 ml cartridges with a ceiling value of $9,023.44 under a firm fixed price arrangement. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,521.52, is for the supply of Imitrex 6 mg/0.5 ml cartridges to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a $2,451.26 delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injector (0.5 mL). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive award outside of any set-aside program. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $14,682.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL cartridges (0.5 mL), with an ultimate completion date of August 1, 2025. This non-set-aside contract was competitively awarded on July 31, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,062.66 firm fixed-price contract is for the supply of Imitrex 6 mg/0.5 ml cartridges to support U.S. government medical requirements. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. There is no set-aside designation noted for this award. Amerisourcebergen...
- AmerisourceBergen Drug Corp was awarded a $4,896.10 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 29, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,179.74 firm fixed-price delivery order is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEKADelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,000.13 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges. This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance at the awardee's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement needs, particularly supporting Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contracts with the DLA Medical Supply Chain covering a wide spectrum of pharmaceutical products and medical supplies. The DLA Troop Support Medical contract under which this delivery order falls enables the company to supply medications, vaccines, syringes, vials, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/12/25 |